The benefits, costs and feasibility of a low incidence COVID-19 strategy
暂无分享，去创建一个
Emil N. Iftekhar | P. Wilmes | M. Perc | V. Priesemann | P. Willeit | E. Glaab | C. Lionis | E. Schernhammer | E. Szczurek | G. Pavlakis | Barbara Prainsack | S. Tsiodras | H. Machado | A. Skupin | T. Czypionka | M. Pickersgill | J. Krutzinna | S. Bauer | Emil Iftekhar | A. Calero Valdez | S. Cuschieri | Evan Grill | C. Martins | E. Petelos | Elena Petelos | Emil N Iftekhar | André Calero Valdez